Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia

Schizophrenia Research

Volumn 41, Issue 3, 2000, Pages 389-395

  Ende, Gabriele ^a   Braus, Dieter F ^a   Walter, Sigrid ^a   Weber Fahr, Wolfgang ^a   Soher, Brian ^b   Maudsley, Andrew A ^b   Henn, Fritz A ^a  

^a Ctrl Institute of Mental Health J5   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anterior cingulate region; N acetyl aspartate; NAA

Indexed keywords

CLOZAPINE; N ACETYLASPARTIC ACID; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MENTAL DISEASE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; ASPARTIC ACID; CHRONIC DISEASE; CLOZAPINE; CREATINE; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PHOSPHOCREATINE; REFERENCE VALUES; RISPERIDONE; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 0033954915     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(99)00089-4     Document Type: Article

References (30)

1. Diagnostic and statistical manual of mental disorders DSM-III-R. 1987;American Psychiatric Press Inc. Washington, DC.
2. Anderton B.H. Changes in the ageing brain in health and disease. Phil. Trans. R. Soc. Lond. B. Biol. Sci. 29:1997;1781-1792.
3. Bartha R., Williamson P.C., Drost D.J., Malla A., Carr T.J., Cortese L., Canaran G., Rylett R.J., Neufeld R.W.J. Measurement of glutamate and glutamine in the medial prefrontal cortex of never-treated schizophrenic patients and healthy controls by proton magnetic resonance spectroscopy. Arch. Gen. Psychiatry. 54:1997;959-965.
4. Bertolino A., Nawroz S., Mattay V.S., Barnett A.S., Duyn J.H., Moonen C.T.W., Frank J.A., Tedeschi G., Weinberger D.R. Regional specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am. J. Psychiatry. 153:1996;1554-1563.
5. Buchsbaum M.S., Hazlett E.A. Functional brain imaging and aging in schizophrenia. Schizophr. Res. 27:1997;129-141.
6. Christiansen P., Toft P., Larsson H.B., Stubgaard M., Henriksen O. The concentration of N-acetyl aspartate, creatine+phosphocreatine, and choline in different parts of the brain in adulthood and senium. Magn. Reson. Imaging. 11:1993;799-806.
7. Deicken R.F., Zhou L., Schuff N., Weiner M.W. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Schizophr. Res. 27:1997;65-71.
8. DeLisi L.E., Tew W., Xie S., Hoff A.L., Sakuma M., Kushner M., Lee G., Shedlack K., Smith A.M. A prospective follow-up study of brain morphology and cognition in first-episode schizophrenic patients: preliminary findings. Biol. Psychiatry. 38:1995;349-360.
9. DeLisi L.E., Sakuma M., Tew W., Kushner M., Hoff A.L., Grimson R. Schizophrenia as a chronic active brain process: a study of progressive brain structural change subsequent to the onset of schizophrenia. Psychiatry Res. 74:1997;129-140.
10. Deutch A.Y., Duman R.S. The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience. 70:1996;377-389.
11. Ende G., Laxer K.D., Knowlton R., Schuff N., Matson G.B., Weiner M.W. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology. 202:1997;809-818.
12. Ende G., Braus D.F., Kühnen, Henn F.A. Proton MRSI in the Cingulate Gyrus of Schizophrenic Patients. Proceedings ISMRM, Vancouver. 1997;1166.
13. Henderson G., Tomlinson B.E., Gibson P.H. Cell counts in human cerebral cortex in normal adults throughout life using image analysis computer. J. Neurol. 21:1980;530-539.
14. Jentsch J.D., Redmond D.E. Jr., Elsworth J.D., Taylor J.R., Youngren K.D., Roth R.H. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine. Science. 277:1997;953-955.
15. Madsen A.L., Keidling N., Karle A., Esbjerg S., Hemmingsen R. Neuroleptics in progressive structural brain abnormalities in psychiatric illness. Lancet. 352:1998;784-785.
16. Maudsley A.A., Matson G.B., Hugg J.W., Weiner M.W. Reduced phase encoding in spectroscopic imaging. Magn. Reson. Med. 31:1994;645-651.
17. Meltzer H.Y., Thompson P.A., Lee M.A., Ranjan R. Neuropsychologic deficits in schizophrenia: relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology. 14:1996;27-33.
18. Michaelis T., Merboldt K.D., Bruhn H., Hänicke W., Frahm J. Absolute concentration of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology. 187:1993;219-227.
19. O'Callaghan E., Buckley P., Redmond O., Stack J., Ennis J.T., Larkin C., Waddington J.L. Abnormalities of cerebral structure in schizophrenia on magnetic resonance imaging: interpretation in relation to the neurodevelopmental hypothesis. J. R. Soc. Med. 85:1992;227-231.
20. Pfefferbaum A., Mathalon D.H., Sullivan E.V., Rawles J.M., Zipursky R.B., Lim K.O. A quantitative magnetic resonance imaging study of changes in brain morphology from infancy to late adulthood. Arch. Neurol. 51:1994;874-887.
21. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328.
22. Robertson G.S., Matsumura H., Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271:1994;1058-1066.
23. Soher B.J., van Zijl P.C., Duyn J.H., Barker P.B. Quantitative proton MR spectroscopic imaging of the human brain. Magn. Reson. Med. 35:1996;356-363.
24. Soher B.J., Young K., Govindaraju V., Maudsley A.A. Automated spectral analysis III: application to in-vivo proton MR spectroscopy and spectroscopic imaging. Magn. Reson. Med. 40:1998;822-831.
25. Sullivan E.V., Marsh L., Mathalon D.H., Lim K.O., Pfefferbaum A. Age-related decline in MRI volumes of temporal lobe gray matter but not hippocampus. Neurobiol. Aging. 16:1995;591-606.
26. Terry R.D., DeTeresa R., Hansen L.A. Neocortical cell counts in normal human adult aging. Ann. Neurol. 21:1987;530-539.
27. Weinberger D.R., Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr. Res. 16:1995;87-110.
28. Woods B.T. Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am. J. Psychiatry. 155:1998;1661-1670.
29. Young K., Govindaraju V., Soher B.J., Maudsley A.A. Automated spectral analysis I: formation of a priori information by spectral simulation. Magn. Reson. Med. 40:1998;812-815.
30. Young K., Soher B.J., Maudsley A.A. Automated Spectral Analysis II: Application of wavelet shrinkage for characterization of non-parameterized signals. Magn. Reson. Med. 40:1998;816-821.